Response to the letter to the editor by Susan Thorpe et al.: how predictive are in vitro assays for cytokine release syndrome in vivo? A comparison of methods reveals worrying differences in sensitivity and frequency of response.
Biologics Safety and Disposition, Preclinical Safety, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Werk Klybeck, Basel, Switzerland.
Babette
B
Wolf
Hannah
H
Morgan
Frank
F
Brennan
Jennifer
J
Krieg
Zaahira
Z
Gani
Stewart
S
Jones
Andrea
A
Kiessling
D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000276:immunology*; D016207:Cytokines / Q000097:blood*; D006801:Humans; D007154:Immune System Diseases / Q000175:diagnosis*
D061067:Antibodies, Monoclonal, Humanized; D016207:Cytokines